The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice ☆
暂无分享,去创建一个
[1] A. Mantovani,et al. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. , 2013, Immunology.
[2] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] Terence Dwyer,et al. Regional Variation in Multiple Sclerosis Prevalence in Australia and Its Association with Ambient Ultraviolet Radiation , 2001, Neuroepidemiology.
[4] H. DeLuca,et al. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. , 2001, The Journal of nutrition.
[5] A. Norman,et al. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein , 2001, The Journal of Steroid Biochemistry and Molecular Biology.
[6] Mustafa Dosemeci,et al. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.
[7] H. DeLuca,et al. In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). , 2000, Archives of biochemistry and biophysics.
[8] R. Kumar,et al. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.
[9] R. Baron,et al. Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.
[10] H. DeLuca,et al. Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. , 1999, The Journal of nutrition.
[11] P. Gallien,et al. Sensory-motor and genito-sphincter dysfunctions in multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] S. Patten,et al. Symptomatic therapies of multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] D. Dean,et al. 1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2 , 1999, Steroids.
[14] M. A. Qureshi,et al. Vitamin D deficiency alters the immune responses of broiler chicks. , 1998, Poultry science.
[15] R. Baron,et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] Tatsuya Yoshizawa,et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning , 1997, Nature Genetics.
[17] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. DeLuca,et al. Effect of 1,25-dihydroxyvitamin D3 on mouse thymus: role of extracellular calcium. , 1996, Biochimica et biophysica acta.
[19] S. Sasaki,et al. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. , 1995, American journal of epidemiology.
[20] A. Keskinoğlu,et al. Lymphocyte subpopulations in children with vitamin D deficient rickets , 1995, Acta paediatrica Japonica : Overseas edition.
[21] H. DeLuca,et al. Vitamin D deficiency suppresses cell-mediated immunity in vivo. , 1993, Archives of biochemistry and biophysics.
[22] J. Lemire,et al. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.
[23] J. Mcleod,et al. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? , 1990, Journal of neurology, neurosurgery, and psychiatry.
[24] M. Alter,et al. Distribution of multiple sclerosis. , 1973, Lancet.
[25] R. Peto,et al. Smoking and cancer. , 1973, Lancet.
[26] K. Westlund. DISTRIBUTION AND MORTALITY TIME TREND OF MULTIPLE SCLEROSIS AND SOME OTHER DISEASES IN NORWAY , 1970, Acta neurologica Scandinavica.
[27] J. Kurtzke. ON THE FINE STRUCTURE OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS , 1967, Acta neurologica Scandinavica.
[28] S. Parodi,et al. Mortality trend for multiple sclerosis in Italy (1974–1993) , 2004, European Journal of Epidemiology.
[29] P. Goldberg. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. (A viewpoint). Part 1. Sunlight, dietary factors and epidemiology. , 1974 .
[30] R. Martenson,et al. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.